B Acute Lymphoblastic Leukemia, BCR-ABL1-Like

B Acute Lymphoblastic Leukemia, BCR-ABL1-Like — Trials · CancerIndex

Clinical trials

Registered studies

7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Children's Oncology Group
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07454226	ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL	recruiting	N/A	92	Institute of Hematology & Blood Diseases Hospital, ChinaOTHER	1	May 13, 2026	clinicaltrials

Data updated 22 days agoSource updated May 13, 2026source: clinicaltrials